iShares Genomics Immunology and Healthcare ETF
IDNA$29.88 -0.23 (-0.76%)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 19, 2025 | $0.16 | 2025-12-16 | 2025-12-16 |
| June 20, 2025 | $0.15 | 2025-06-16 | 2025-06-16 |
| December 20, 2024 | $0.11 | 2024-12-17 | 2024-12-17 |
| June 17, 2024 | $0.11 | 2024-06-11 | 2024-06-11 |
| December 27, 2023 | $0.17 | 2023-12-20 | 2023-12-21 |
Dividends Summary
- Consistent Payer: iShares Genomics Immunology and Healthcare ETF has rewarded shareholders with 12 dividend payments over the past 6 years.
- Total Returned Value: Investors who held IDNA shares during this period received a total of $1.58 per share in dividend income.
- Latest Payout: The most recent dividend of $0.16/share was paid 35 days ago, on December 19, 2025.
- Dividend Growth: Since 2019, the dividend payout has decreased by 35.3%, from $0.24 to $0.16.
Company News
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
Merck & Co. has agreed to acquire SpringWorks Therapeutics for around $4 billion, a 26% premium over SpringWorks' 20-day average price. The acquisition will boost Merck's revenue and expand its U.S. healthcare presence, particularly in rare tumor treatments.
Top Thematic ETF Ideas for 2024: AI & More
BlackRock's Jay Jacobs discusses best investing themes for 2024.
Top Thematic ETF Ideas for 2024: AI & More
BlackRock's Jay Jacobs discusses best investing themes for 2024.
Time to Buy Moderna-Heavy ETFs on Vaccine Optimism?
Shares of Moderna witnessed a significant increase of more than 13% on Jan 2, 2024, driven by Oppenheimer's decision to upgrade the stock to "outperform," as quoted on CNBC.
